호스피스.완화의료 환자에게 적용한 방사선 치료의 부작용과 대처법 = The Adverse Effects of Radiotherapy and Its Management in the Hospice and Palliative Care Patients

다국어 초록 (Multilingual Abstract)

Recent advances in techniques and strategies use to detect cancer in its early stages and to treat it effectively has the survival rate of cancer patients and the number of long-term cancer survivors continually increasing. Unfortunately, many cancer survivors are at risk for various late and long-term effects of cancer treatments including the radiotherapy. Long-term cancer survivors can be also seen for a hospice and palliative care because of cancer recurrence and they are at risk of delayed reactions to radiotherapy. So, the understanding and knowledge of radiation reactions is required for the proper medical diagnosis, management, and coordination of the potential reactions that may occur in these care setting. In effort to increase the survival rate in cancer patients and to decrease the adverse effects of cancer treatment, many clinical studies have been and continue to be conducted. The efforts of these studies have thus resulted in the advancement of cancer treatments. Regrettably, the overall interest in how to manage adverse effects of cancer treatment such as radiotherapy appears seemingly low in clinical practice and its advanced studies as a whole are delayed and deficient. It is imperative that the medical community show an enthusiastic interest in the aftercare of cancer patients and cancer survivors in order to create a complementary integrative approach that will eliminate radiotherapy related pain/discomfort or illness in hospice and palliative care settings.

참고문헌 (Reference)

• 1 박진혁, "하악골에 발생한 방사선골괴사증 증례보고 및 문헌고찰" 대한구강악안면외과학회 32 (32): 458-, 2006
• 2 박용, "암 치료중 발생하는 구강과 위장관 점막염" 대한의사협회 52 (52): 897-906, 2009
• 3 김명세, "세기조절방사선치료(IMRT)로 치료한 비소세포폐암 환자에서의 방사선 폐렴" 대한방사선종양학회 26 (26): 35-44, 2008
• 4 허승재, "골반 방사선 치료후의 골 변화와 손상" 대한방사선종양학회 27 (27): 1-9, 2009
• 5 Eisbruch A, "Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer" 50 : 695-704, 2001
• 6 Perez CA, "Uterine Cervix, In Perez and Brady’s principles and practice of radiation oncology. 5th ed" Lippincott Williams & Wilkins 1532-1609, 2008
• 7 Aziz NM, "Trends and advances in cancer survivorship research: challenge and opportunity" 13 : 248-266, 2003
• 8 Corman JM, "Treatment of radiation induced hemorrhagic cystitis with hyperbaric oxygen" 169 (169): 2200-2202, 2003
• 9 Volterrani F, "Topical benzydamine in the treatment of vaginal radiomucositis" 9 : 169-171, 1987
• 10 Wu HG, "Therapeutic effect of recombinant human epidermal growth factor (RhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer: a doubleblind placebo-controlled prospective phase 2 multi-institutional clinical trial" 115 : 3699-3708, 2009
• 11 Marks LB, "The utility of SPECT lung perfusion scans in minimizing and assessing the physiologic consequences of thoracic irradiation" 26 : 659-668, 1993
• 12 Lee D, "The use of recombinant human keratinocyte growth factor (palifermin) to ameliorate treatment-induced mucositis" 1 : 20-22, 2003
• 13 Hart GB, "The treatment of radiation necrosis with hyperbaric oxygen (OHP)" 37 : 2580-2585, 1976
• 14 Burger PC, "The morphologic effects of radiation administered therapeutically for intracranial gliomas: a postmortem study of 25 cases" 44 (44): 1256-1272, 1979
• 15 Incrocci L, "Tadalafil (Cialis) and erectile dysfunction after radiotherapy for prostate cancer: an open-label extension of a blinded trial" 70 : 1190-1193, 2007
• 16 King V, "Symptomatic coronary artery disease after mantle irradiation for Hodgkin’s disease" 36 : 881-889, 1996
• 17 Deng G, "Supportive care and quality of life, In Perez and Brady’s principles and practice of radiation oncology. 5th ed" Lippincott Williams & Wilkins 2011-2020, 2008
• 18 Wood G, "Skin changes, In: Radiation toxicity: a practical guide" Springer Science+Media Business, Inc 170-181, 2006
• 19 Wilmoth MC, "Sexual implications of gynecologic cancer treatments" 29 : 413-421, 2000
• 20 Incrocci L, "Sexual (dys)function after radiotherapy for prostate cancer: a review" 52 : 681-693, 2002
• 21 Fransson P, "Self-assessed sexual function after pelvic irradiation for prostate carcinoma. Comparison with an agematched control group" 78 : 1066-1078, 1996
• 22 Heidenreich PA, "Screening for coronary artery disease after mediastinal irradiation for Hodgkin’s disease" 25 : 43-49, 2007
• 23 Shaha AR, "Resection and immediate microvascular reconstruction in the management of osteoradionecrosis of the mandible" 19 (19): 406-411, 1997
• 24 Teshima T, "Rectal bleeding after conformal 3D treatment of prostate cancer: time to occurrence, response to treatment and duration of morbidity" 39 : 77-83, 1997
• 25 Delanian S, "Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis" 21 (21): 2545-2550, 2003
• 26 Komaki R, "Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: preliminary results" 12 (12): 46-49, 2002
• 27 Ship JA, "Radiotherapy-induced salivary dysfunction" 31 (31): 29-36, 2004
• 28 Hoskin PJ, "Radiotherapy in symptom management, In Oxford textbook of palliative medicine. 3rd ed" Oxford University Press 239-255, 2004
• 29 Malkinson FD, "Radiobiology of the skin: review of some effects on epidermis and hair" 77 : 133-138, 1981
• 30 Hall EJ, "Radiobiology for the radiologist. 6th ed" Lippincott Williams & Wilkins 327-344, 2006
• 31 Hall EJ, "Radiobiology for the radiologist. 6th ed" Lippincott Williams & Wilkins 47-59, 2006
• 32 Hall EJ, "Radiobiology for the radiologist. 6th ed" Lippincott Williams & Wilkins 5-14, 2006
• 33 Chambers MS, "Radiationinduced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management" 26 : 796-807, 2004
• 34 Valdez IH, "Radiation-induced salivary dysfunction: clinical course and significance" 11 : 252-255, 1991
• 35 Kochhar R, "Radiation-induced proctosigmoiditis. Prospective, randomized, double-blind controlled trial of oral sulfasalazine plus rectal steroids versus rectal sucralfate" 36 (36): 103-107, 1991
• 36 Marks LB, "Radiation-induced lung injury" 13 (13): 333-345, 2003
• 37 Chopra RR, "Radiation therapy-related toxicity (including pneumonitis and fibrosis)" 27 : 293-310, 2009
• 38 Babb RR, "Radiation proctitis: a review" 91 (91): 1309-1311, 1996
• 39 Bradley J, "Radiation pneumonitis and esophagitis in thoracic irradiation, In Radiation toxicity: a practical guide" Springer Science+Media Business, Inc 43-53, 2006
• 40 Monje ML, "Radiation injury and neurogenesis" 16 (16): 129-134, 2003
• 41 Davis SD, "Radiation effects on the lung: clinical features, pathology, and imaging findings" 159 (159): 1157-1164, 1992
• 42 Siker ML, "Primary intracranial neoplasms, In Perez and Brady’s principles and practice of radiation oncology. 5th ed" Lippincott Williams & Wilkins 717-750, 2008
• 43 Pitkin RM, "Postirradiation vaginitis. An evaluation of prophylaxis with topical estrogen" 99 : 417-421, 1971
• 44 Brizel DM, "Phase III randomized trial of amifostine as a radioprotector in head and neck cancer" 18 : 3339-3345, 2000
• 45 Brizel DM, "Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma" 26 : 2489-2496, 2008
• 46 Archambeau JO, "Pathophysiology of irradiated skin and breast" 31 : 1171-1185, 1995
• 47 Reuther T, "Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients-a report of a thirty year retrospective review" 32 : 289-295, 2003
• 48 Wiseman LR, "Oral pilocarpine: a review of its pharmacological properties and clinical potential in xerostomia" 49 : 143-155, 1995
• 49 Lee AWM, "Nasopharynx, In Perez and Brady’s principles and practice of radiation oncology. 5th ed" Lippincott Williams & Wilkins 820-857, 2008
• 50 Keefe DM, "Mucositis study section of the multinational association of supportive care in cancer and the international society for oral oncology" 109 (109): 820-831, 2007
• 51 Meyers CA, "Methylphenidate therapy improves cognition, mood, and function of brain tumor patients" 16 (16): 2522-2527, 1998
• 52 Cho JH, "Manual acupuncture improved quality of life in cancer patients with radiation-induced xerostomia" Mary Ann Liebert Inc. 14 (14): 523-526, 2008
• 53 Blanco AI, "Management of radiation-induced head and neck injury, InRadiation toxicity: a practical guide" Springer Science+Media Business, Inc 23-39, 2006
• 54 Grigsby PW, "Late injury of cancer therapy on the female reproductive tract" 31 : 1281-1299, 1995
• 55 Constine LS, "Late effects of cancer treatment on normal tissues, In Perez and Brady’s principles and practice of radiation oncology. 5th ed" Lippincott Williams & Wilkins 320-355, 2008
• 56 Peissner W, "Ionizing radiationinduced apoptosis of proliferating stem cells in the dentate gyrus of the adult rat hippocampus" 71 (71): 61-68, 1999
• 57 Goodman M, "Integumentary and mucous membrane alterations, In Cancer nursing: principles and practice. 4th ed" Jones and Bartlett 768-822, 1997
• 58 Constine LS, "Hypothalamic-pituitary dysfunction after radiation for brain tumors" 328 (328): 87-94, 1993
• 59 Tibbles PM, "Hyperbaric-oxygen therapy" 334 (334): 1642-1648, 1996
• 60 Feldmeier JJ, "Hyperbaric oxygen as an adjunctive treatment for delayed radiation injury of the chest wall: a retrospective review of twenty-three cases" 22 (22): 383-393, 1995
• 61 Robinson JW, "Erectile functioning of men treated for prostate carcinoma" 79 : 538-544, 1997
• 62 Zelefsky MJ, "Efficacy of oral sildenafil in patients with erectile dysfunction after radiotherapy for carcinoma of the prostate" 53 : 775-778, 1999
• 63 Wong JK, "Conservative management of osteoradionecrosis" 84 (84): 16-21, 1997
• 64 Henry RG, "Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas" 21 (21): 357-366, 2000
• 65 Monson JM, "Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma" 82 (82): 842-850, 1998
• 66 Marks JE, "Cerebral radionecrosis: incidence and risk in relation to dose, time, fractionation and volume" 7 : 243-252, 1981
• 67 Ries LA, "Cancer incidence and survival among children and adolescents: United States SEER program 1975-1995" National Cancer Institute 1999
• 68 American Cancer Society, "Cancer facts and figures 2003" American Cancer Society 2003
• 69 Olsen EA, "Anagen hair loss: Radiation, In Disorders of hair growth: diagnosis and treatment" McGraw Hill 225-226, 1994
• 70 Cartwright-Alcarese F, "Addressing sexual dysfunction following radiation therapy for a gynecologic malignancy" 22 : 1227-1232, 1995
• 71 Morganstein WM, "Acupuncture in the treatment of xerostomia: clinical report" 53 (53): 223-227, 2005
• 72 Johnstone PA, "Acupuncture for pilocarpine-resistant xerostomia following radiotherapy for head and neck malignancies" 50 : 353-357, 2001
• 73 Anné PR, "A phase II trial of subcutaneous amifostine and radiation therapy in patients with head and neck cancer" 67 : 445-452, 2007
• 74 LeVeque FG, "A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients" 11 : 1124-1131, 1993